scholarly journals Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension

2015 ◽  
Vol 17 (6) ◽  
pp. 599-602 ◽  
Author(s):  
S.‐M. Jin ◽  
C.‐Y. Park ◽  
Y. M. Cho ◽  
B. J. Ku ◽  
C. W. Ahn ◽  
...  
2019 ◽  
Vol 21 (11) ◽  
pp. 2496-2504 ◽  
Author(s):  
Yuan‐Di C. Halvorsen ◽  
Geoffrey A. Walford ◽  
Joseph Massaro ◽  
Robert P. Aftring ◽  
Mason W. Freeman

Sign in / Sign up

Export Citation Format

Share Document